Answers - Real Estate

Probably the most popular real estate debate today centers around the San Francisco Bay Area home sales market and whether or not now is a good time to buy a home. With recent changes in the m

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

arket, most buyers are sitting on the sidelines trying to weigh the pros and cons of jumping in to seemingly unpredictable and turbulent waters. While both home prices and home sales are falli

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ng nationwide, the market in the San Francisco Bay Area is a bit of an anomaly. According to DataQuick Information Systems, a real estate research firm, though fewer properties are selling in

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

the Bay Area, and real estate inventories are growing, overall home prices are still going through the roof. It has been reported by news media that the median price for an existing single fam

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ily home rose to a record $720,000 in April of 2007 though April’s sales count was the lowest in 12 years. So what is driving the market, and is now a good time to buy?

The Wealth Factor<

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

/b>
The Bay Area housing market is significantly impacted by the level of wealth shared by the people buying homes there right now. According to the California Association of Realtors, h

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

igher-priced markets have been performing better than lower-priced or "starter home" areas in terms of the strength of both sales and price. On the other end of the spectrum, recent sub-prime

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

mortgage market woes have stifled the ability of people with little money to put down, and those who have poor or marginal credit; to qualify for a home loan. This segment is being squeezed ou

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

t of the market by tougher lending requirements. With fewer people in the starter home demographic able to qualify for a home, both home prices and home sales in lower-priced areas have been s

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

tagnant or declining. Whether you are looking for a starter home, or you are looking to move up; if you are trying to determine whether or not now is the right time to buy, it really all depen

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ds on 1.) your credit, 2.) your overall ability to qualify for a loan, and 3.) your ability to come in with a significant down-payment.

If You Have a Weak Credit Rating, Clean Up Your Cred

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

it
In recent years, there really was a loan out there for almost everyone--though, if a buyer’s credit was less than perfect it could really become costly. Today, however, the days of

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

no down-payment loans are quietly fading into the distance even for the highly credit worthy. So, if your credit report shows excessive late payments, collection accounts, charge-offs or any

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

other derogatory items, now would be a good time to put "homeownership" on the back burner and move "cleaning up your credit" to the forefront. That way, when a solid loan program is available

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

for you, you will be able to enter into homeownership from a position of financial strength.

Taking Advantage of the Buyers Market
If your credit is strong, you have money to put

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

down on a home, your mortgage payments are manageable for you, and you plan to stay put for more than 5 year; by all means throw your hat into the ring—-especially if you are looking for a st

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

arter home in a moderately priced area. While you probably won’t walk away with a “steal” the odds are in your favor that you will be able to purchase a home at a great price. Don't be overly

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

concerned about whether or not home prices will slip further in the coming months. If you are planning to stay put for a little while, it really doesn't matter.

Give Up on Trying to Time t

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

he Market
What many people don’t understand is that it is virtually impossible to “time the market.” Over time, home prices in the San Francisco Bay Area have risen significantly. So,

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

while the San Francisco Bay Area is in a unique type of slump consisting of slowing sales and rising prices, whether or not now is the right time to buy, depends on your individual situation.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Answers - San Francisco Bay Area Real Estate - Buy Now Or Wait It Out?

Related Articles: